• Overfølsomhed over for det aktive stof eller over for et eller flere af hjælpestofferne. • Tumorer i ovarierne, mammae, uterus, testikler, hypofysen eller hypothalamus. • Udiagnosticeret vaginalblødning.
• Hypersensitivity to the active substance or to any of the excipients. • Tumours of the ovary, breast, uterus, testis, pituitary or hypothalamus. • Undiagnosed vaginal bleeding. • Primary ovarian failure.